ZYME Q2 2024 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$19M+174.8% YoY

Gross Profit

$19M100.0% margin

Operating Income

-$43M-222.9% margin

Net Income

-$38M-195.8% margin

EPS (Diluted)

$-0.49

QoQ Revenue Growth

+91.9%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$26M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$516M

Total Liabilities

$109M

Stockholders' Equity

$406M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$7M	+174.8%
Gross Profit	$19M	-$32M	+159.4%
Operating Income	-$43M	-$54M	+20.7%
Net Income	-$38M	-$51M	+26.3%

Revenue Segments

Milestone Revenue

$8M88%

Research Support Payments And Other Service

$1M12%